Macular Edema Market Estimated to Grow at a CAGR of 10.43% in the Forecast Period

DataM Intelligence’s latest market report titled ‘Global Macular Edema Market - Size, Share and Forecast (2019 - 2026)’ reflects the size, scope, industry dynamics, major firms and future trends in this market. The research report analyses drivers and restraints operating in this competitive space to present a better in-depth of the underlying market opportunities.

The global macular edema market was valued at USD 6.24 billion in 2017 and the market is estimated to grow at a CAGR of 10.43% in the forecasted period (2018-2025) to reach a market value of USD XX billion by 2025.

Global Macular Edema Market Growth Factors
Macular Edema is a condition in which fluid gathers in macular and leads to vision impairment and loss of vision in certain conditions.
Advancements in technologies in the development of new drug delivery systems, the introduction of new drug combinations, rise in macular oedema patients are the major factors driving the growth of the macular oedema market across the globe.
Increasing diabetic population which in turn could result in macular edema is also one of the factors driving the growth of the market. Stringent regulations across various regions, availability of alternative therapies, and the high cost of the drugs/medication are the major factor restraining the growth of the market.

Get a free sample of the report - https://www.datamintelligence.com/research-report/macular-edema-market

Global Macular Edema Market Segmentation
The macular edema market is segmented by clinical trial analysis, by molecular type, and by geography.
By geography, North America has the largest market share in 2017 accounting for more than half of the market value and this is followed by Europe. Emerging markets are witnessing a faster growth in the market with Asia-Pacific region growing at a faster growth rate.

Some of the major companies in global macular edema therapeutics market include
Novartis
Roche
Pfizer
Regeneron Pharmaceuticals

Macular Edema Market Competitive Landscape
The global macular edema market is a consolidated market with top 4 companies accounting for the largest market share. Some of the recent industry developments include
FDA approves Roche’s “Lucentis” for treatment of diabetic retinopathy in people with diabetic macular edema
Eylea injection recommended for approval for the treatment of visual impairment due to diabetic macular edema in the European Union

To know more information about the report - https://www.datamintelligence.com/research-report/macular-edema-market

Table of contents overview -
1 Methodology and Scope
2. Headlines & Trends
3. Industry Analysis
4. Clinical Trial Analysis
4.1 By Age Group
4.2 By Gender
4.3 By Study Phases
4.4 By Study Type
5. Segmentation by Molecular Type
6. Geographic Analysis
6.1 North America
6.2 Europe
6.3 Asia-Pacific
6.4 South America
7. Competitive Landscape
8. Company Profiles*
9. Appendix

Corporate Address
1st floor, Phoenix Tech Tower, Plot no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana

Email
info@datamintelligence.com

Phone
+1 877-441-4866

About DataM Intelligence

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.

DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery and Automation among others.

This release was published on openPR.